Holen Sie sich die Stockscreener-App
7.37
1.60%
-0.12
Handel nachbörslich:
7.36
-0.010
-0.14%
Schlusskurs vom Vortag:
$7.49
Offen:
$7.55
24-Stunden-Volumen:
172.05K
Relative Volume:
1.01
Marktkapitalisierung:
$275.91M
Einnahmen:
$128.45M
Nettoeinkommen (Verlust:
$6.54M
KGV:
147.40
EPS:
0.05
Netto-Cashflow:
$-8.79M
1W Leistung:
-6.59%
1M Leistung:
+11.16%
6M Leistung:
+11.16%
1J Leistung:
-1.47%
1-Tages-Spanne:
$7.28
$7.63
1-Wochen-Bereich:
$7.28
$8.11
52-Wochen-Spanne:
$4.76
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Firmenname
Lifecore Biomedical Inc
Sektor
Telefon
(952) 368-4300
Adresse
3515 LYMAN BOULEVARD, CHASKA
Vergleichen Sie LFCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.37 | 280.62M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | Eingeleitet | William Blair | Outperform |
| 2024-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Herabstufung | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten
Lifecore Biomedical at Stephens Annual Investment Conference: Strategic Growth Path By Investing.com - Investing.com Canada
Can Lifecore Biomedical Inc. stock surprise with earnings upsideQuarterly Performance Summary & AI Powered Buy and Sell Recommendations - newser.com
Will Lifecore Biomedical Inc. (LDE) stock benefit from sector leadership2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - newser.com
Will Lifecore Biomedical Inc. stock benefit from green energy trendsProfit Target & Daily Oversold Stock Bounce Ideas - newser.com
Is Lifecore Biomedical Inc. stock ready for breakoutStop Loss & Short-Term High Return Strategies - newser.com
What candlestick patterns are forming on Lifecore Biomedical Inc.July 2025 Selloffs & Safe Entry Momentum Tips - newser.com
Should I hold or sell Lifecore Biomedical Inc. stock in 2025July 2025 Recap & Capital Protection Trade Alerts - newser.com
How to interpret RSI for Lifecore Biomedical Inc. stock2025 Bull vs Bear & Consistent Return Investment Signals - newser.com
How Lifecore Biomedical Inc. stock benefits from strong dollarMarket Rally & Expert-Curated Trade Recommendations - newser.com
Why pension funds invest in Lifecore Biomedical Inc. (LDE) stockBull Run & Technical Confirmation Trade Alerts - newser.com
Will Lifecore Biomedical Inc. (LDE) stock see insider accumulation - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Lifecore Biomedical at Jefferies London: Strategic Growth Unveiled By Investing.com - Investing.com Canada
Lifecore Biomedical, Inc. Announces Fiscal Year Change and Strategic Developments - TradingView
Real time pattern detection on Lifecore Biomedical Inc. stockQuarterly Risk Review & Weekly Chart Analysis and Trade Guides - newser.com
Will Lifecore Biomedical Inc. (LDE) stock gain from lower interest ratesQuarterly Market Summary & Risk Managed Investment Strategies - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical (NASDAQ:LFCR) Adds US$54m to Market Cap in the Past 7 Days, Though Investors From Five Years Ago Are Still Down 19% - 富途牛牛
Market reaction to Lifecore Biomedical Inc.’s recent news2025 Sector Review & Safe Entry Point Alerts - newser.com
Is it too late to sell Lifecore Biomedical Inc.Market Growth Review & Capital Protection Trading Alerts - newser.com
Is Lifecore Biomedical Inc. stock affected by interest rate hikesMarket Activity Report & Daily Risk Controlled Trade Plans - Fundação Cultural do Pará
Is Lifecore Biomedical Inc. (LDE) stock undervalued after correctionWeekly Loss Report & Consistent Return Strategy Ideas - newser.com
Will Lifecore Biomedical Inc. (LDE) stock recover faster than industryQuarterly Profit Summary & Reliable Intraday Trade Alerts - newser.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.17%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):